BMJ September 22, 2023, 382 p2167; DOI: https://doi.org/10.1136/bmj.p2167
Cited by...
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care